| Title | Associations of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and Canada. |
| Publication Type | Journal Article |
| Year of Publication | 2017 |
| Authors | Dubrow, Robert, Li Qin, Haiqun Lin, Raúl U. Hernández-Ramírez, Romain S. Neugebauer, Wendy Leyden, Keri N. Althoff, Chad J. Achenbach, Nancy A. Hessol, Sharada P. Modur, Gypsyamber D'Souza, Ronald J. Bosch, Surbhi Grover, Michael A. Horberg, Mari M. Kitahata, Angel M. Mayor, Richard M. Novak, Charles S. Rabkin, Timothy R. Sterling, James J. Goedert, Amy C. Justice, Eric A. Engels, Richard D. Moore, and Michael J. Silverberg |
| Corporate Authors | North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS |
| Journal | Journal of acquired immune deficiency syndromes (1999) |
| Date Published | 2017 Apr 07 |
| ISSN | 1944-7884 |
| Abstract | Kaposi sarcoma (KS) remains common among HIV-infected persons. To better understand KS etiology and to help target prevention efforts, we comprehensively examined a variety of CD4+ T-cell count and HIV-1 RNA viral load (VL) measures, as well as antiretroviral therapy (ART) use, to determine independent predictors of KS risk. |
| DOI | 10.1097/QAI.0000000000001394 |
| Alternate Journal | J. Acquir. Immune Defic. Syndr. |
